Comparison of the Efficacy of Pingxiao Capsule and Shendan Sanjie Capsule Combined with CP Program in the Treatment of Non-small Cell Lung Cancer in StageⅣ
10.6039/j.issn.1001-0408.2015.30.08
- VernacularTitle:平消胶囊与参丹散结胶囊辅助培美曲塞联合卡铂治疗Ⅳ期非小细胞肺癌的疗效比较
- Author:
Shumei WANG
;
Jun LI
- Publication Type:Journal Article
- Keywords:
Pingxiao capsule;
Shendan Sanjie capsule;
Pemetrexed;
Carboplatin;
Non-small cell lung cancer in stageⅣ
- From:
China Pharmacy
2015;(30):4200-4202
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the efficacy and safety of Pingxiao capsule and Shendan Sanjie capsule combined with CP program in the treatment of non-small cell lung cancer (NSCLC) in stage Ⅳ. METHODS:132 NSCLC patients in stage Ⅳwere randomly divided into CP group,CP+Pingxiao group and CP+Shendan Sanjie group. CP group was treated with CP program;based on it,CP+Pingxiao group was orally treated with 6 Pingxiao capsules,3 times a day;CP+Shendan Sanjie group was orally treated with 6 Shendan Sanjie capsules,3 times a day. 21 d was a treatment period,and the efficacy was evaluated after 2 treat-ment periods,improvement of life quality,progression-free survival,1-year survival rate and toxicity reactions were observed. RE-SULTS:The recent effective rate,disease control rate,total improvement rate of life quality,progression-free survival and 1-year survival rate in CP+Pingxiao group and CP+Shendan Sanjie group were significantly higher than CP group,incidences of leukope-nia,thrombocytopenia,gastrointestinal tract and decreased hemoglobin were significantly lower than CP group,the differences were statistically significant(P<0.05);however,there was no significant difference between CP+Pingxiao group and CP+Shendan Sanjie group(P>0.05). CONCLUSIONS:Both Pingxiao capsule and Shendan Sanjie capsule can be combined with CP program in the treatment of NSCLC in stageⅣ,with good safety.
